Three-year survival from diagnosis in surgically treated patients in designated and nondesignated cancer care hospitals in Japan.

ABSTRACT: The Japanese national and prefectural governments have accredited high-capacity, high-experience cancer care hospitals as "designated cancer care hospitals" to standardize cancer care, centralize patients, and improve clinical outcomes, but the performance of these designated hospitals has not been evaluated. We retrospectively compared 3-year patient survival in national, prefectural, and nondesignated cancer care hospitals in 2010-2012 in Osaka using registry-based data of 86 456 surgically treated cancer patients aged 15 years or older. Hazard ratios and 3-year survival probabilities were compared among national, prefectural, and nondesignated hospitals using a Cox proportional hazard regression model. Subgroup analyses for six cancers (stomach, colorectum, lung, breast, uterus, and pro

SUBMITTER: Okawa S 

PROVIDER: S-EPMC8177783 | biostudies-literature | 2021 Jun

REPOSITORIES: biostudies-literature